pteridines has been researched along with HIV in 2 studies
HIV: Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ram, RR | 1 |
| Duatschek, P | 1 |
| Margot, N | 1 |
| Abram, M | 1 |
| Geleziunas, R | 1 |
| Hesselgesser, J | 1 |
| Callebaut, C | 1 |
| Tsai, A | 1 |
| Irrinki, A | 1 |
| Kaur, J | 1 |
| Cihlar, T | 1 |
| Kukolj, G | 1 |
| Sloan, DD | 1 |
| Murry, JP | 1 |
2 other studies available for pteridines and HIV
| Article | Year |
|---|---|
Activation of HIV-specific CD8
Topics: Anti-HIV Agents; CD8-Positive T-Lymphocytes; Dose-Response Relationship, Drug; Flow Cytometry; HIV; | 2020 |
Toll-Like Receptor 7 Agonist GS-9620 Induces HIV Expression and HIV-Specific Immunity in Cells from HIV-Infected Individuals on Suppressive Antiretroviral Therapy.
Topics: Anti-Retroviral Agents; Antibody-Dependent Cell Cytotoxicity; CD8-Positive T-Lymphocytes; Cell Diffe | 2017 |